Blog

In this episode of the Think Neuro podcast, you'll meet a dedicated trio - Dr. David Merrill, Dr. Karen Miller, and Molly Rapozo - who are working collaboratively to combat the debilitating effects of dementia in older individuals. Their approach is holistic, addressing key factors such as diet, exercise, and cognitive training. This collective effort holds significant importance, particularly in light of the limited progress in Alzheimer's drug development. There's no magic pill for maintaining optimal brain health as we age, so they focus on promoting well-established behaviors that have been proven to protect the brain from premature dysfunction. Tune in to this podcast to discover the insights and strategies of this all-star team.

Introducing AD-NeuroScore, an innovative approach to early Alzheimer’s disease detection and tracking. Developed by Jennifer Bramen, PhD, at Pacific Neuroscience Institute Foundation, this novel solution uses advanced MRI technology and a unique algorithm to simplify and improve Alzheimer’s-specific neurodegeneration assessment. 

Discover the unexpected benefits of music for dementia patients from Scott Kaiser, MD. Learn how music therapy can help individuals express themselves, preserve memories, and enhance overall brain health in Alzheimer's and dementia patients, along with best practices for using music in caregiving.

In a study sponsored by Usona Institute and published on August 31, 2023, in the Journal of the American Medical Association, psilocybin showed promise as a treatment for major depressive disorder (MDD).

JAMA Associate Editor Dr. Donald C. Goff, speaks with publication author Dr. Charles L. Raison, from the Usona Institute, about the study, as well as Dr. Rachel Yehuda from Mount Sinai School of Medicine, who wrote an accompanying editorial about the potential benefits of psychedelic therapies.

Pacific Neuroscience Institute's director of Treatment & Research In Psychedelics Center, Dr. Keith Heinzerling, was a co-investigator in this study.

An international study reveals a link between abdominal body fat and brain atrophy, potentially leading to dementia. Explore the groundbreaking findings from Pacific Neuroscience Institute's Brain Health Center, shedding light on how abdominal fat affects brain health and Alzheimer's risk. Learn how this research can influence early intervention and healthier lifestyles to mitigate dementia risks.

Discover Pacific Neuroscience Institute's new Speech-Language Pathology Program, offering personalized and evidence-based care for speech, language, swallowing, and cognitive communication impairments. Meet our expert team and experience compassionate care that enhances communication, swallow function, and overall well-being.

We are excited to announce the expansion of our psychedelics program into a new center of excellence: The Pacific Treatment & Research in Psychedelics (TRIP). As a leader in psychedelic research, Pacific Neuroscience Institute (PNI) continues to pioneer innovative mental health solutions.

Director of Geriatric Cognitive Health at Pacific Neuroscience Institute®(PNI®), Scott Kaiser, MD, discusses the "polite" respectful language and attitudes towards aging, combatting ageism and stereotypes, and promoting inclusive and respectful communication for aging experiences.

Brain fog can disrupt memory, focus, and overall well-being. Discover its diverse origins and how it affects neurological mechanisms. Plus, learn effective coping strategies to regain mental clarity and improve cognitive health.

Discover the transformative power of psychedelics for treating traumatic brain injuries (TBI) and mental health conditions. Witness former UFC fighter Ian McCall's inspiring recovery using psilocybin mushrooms. Join the conversation on revolutionizing mental health treatment with Daniel F. Kelly, MD, CEO of Pacific Neuroscience Institute (PNI) and board-certified neurosurgeon.